Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities

References

• Deborah V. Novack RF. Osteoclast motility: Putting the brakes on bone resorption. Ageing Res Rev 2011; 10:54-61; PMID:19788940; http://dx.doi.org/10.1016/j.arr.2009.09.005
   PubMed Web of Science ®Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423:337-42; PMID:12748652; http://dx.doi.org/10.1038/nature01658
   PubMed Web of Science ®Google Scholar
• Wiebe SH, Hafezi M, Sandhu HS, Sims SM, Dixon SJ. Osteoclast activation in inflammatory periodontal diseases. Oral Dis 1996; 2:167-80; PMID:8957930; http://dx.doi.org/10.1111/j.1601-0825.1996.tb00218.x
   PubMedGoogle Scholar
• Helfrich MH. Osteoclast diseases and dental abnormalities. Arch Oral Biol 2005; 50:115-22; PMID:15721137; http://dx.doi.org/10.1016/j.archoralbio.2004.11.016
   PubMed Web of Science ®Google Scholar
• Shu G, Yamamoto K, Nagashima M. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. Mod Rheumatol 2006; 16:343-9; PMID:17164994; http://dx.doi.org/10.3109/s10165-006-0515-1
   PubMedGoogle Scholar
• Lee TH, Fevold KL, Muguruma Y, Lottsfeldt JL, Lee MY. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development. Exp Hematol 1994; 22:66-73; PMID:8282061
   PubMed Web of Science ®Google Scholar
• Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-76; PMID:9568710; http://dx.doi.org/10.1016/S0092-8674(00)81569-X
   PubMed Web of Science ®Google Scholar
• Baud'huin M, Lamoureux F, Duplomb L, Redini F, Heymann D. RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases. Cell Mol Life Sci 2007; 64:2334-50; PMID:17530461; http://dx.doi.org/10.1007/s00018-007-7104-0
   PubMed Web of Science ®Google Scholar
• Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004; 15:457-75; http://dx.doi.org/10.1016/j.cytogfr.2004.06.004
   PubMed Web of Science ®Google Scholar
• Makihira S, Mine Y, Nikawa H, Shuto T, Kosaka E, Sugiyama M, Hosokawa R. Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. J Mater Sci Mater Med 2010; 21:647-53; PMID:19834789; http://dx.doi.org/10.1007/s10856-009-3891-1
   PubMed Web of Science ®Google Scholar
• Nakamura I, Duong le T, Rodan SB, Rodan GA. Involvement of α(v)beta3 integrins in osteoclast function. J Bone Miner Metab 2007; 25:337-44; PMID:17968485; http://dx.doi.org/10.1007/s00774-007-0773-9
   PubMed Web of Science ®Google Scholar
• Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R, et al. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(−/−) mice. J Cell Biol 2007; 178:1053-64
   PubMed Web of Science ®Google Scholar
• Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, Bonnette PC, Baumann AP, Hambor JE, Grasser WA 3rd, et al. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc Natl Acad Sci U S A 2007; 104:10619-24; PMID:17537919; http://dx.doi.org/10.1073/pnas.0701421104
   PubMed Web of Science ®Google Scholar
• Avraham H, Park SY, Schinkmann K, Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell Signal 2000; 12:123-33; PMID:10704819; http://dx.doi.org/10.1016/S0898-6568(99)00076-5
   PubMed Web of Science ®Google Scholar
• Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996; 383:547-50; PMID:8849729; http://dx.doi.org/10.1038/383547a0
   PubMed Web of Science ®Google Scholar
• Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999; 71:435-78; PMID:10354709; http://dx.doi.org/10.1016/S0079-6107(98)00052-2
   PubMed Web of Science ®Google Scholar
• Jr. RR. Src protein–tyrosine kinase structure and regulation. Biochem Biophys Res Commun 2004; 324:1155-64; PMID:15504335
   PubMed Web of Science ®Google Scholar
• Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta 1996; 1287:121-49; PMID:8672527
   PubMed Web of Science ®Google Scholar
• Zheng XM, Resnick RJ, Shalloway D. A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J 2000; 19:964-78; PMID:10698938; http://dx.doi.org/10.1093/emboj/19.5.964
   PubMed Web of Science ®Google Scholar
• Fu YX, Gu JH, Zhang YR, Tong XS, Zhao HY, Yuan Y, et al. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. J Vet Sci 2013; 14:405-12; PMID:23820214; http://dx.doi.org/10.4142/jvs.2013.14.4.405
   PubMed Web of Science ®Google Scholar
• Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong le T. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J Biol Chem 2003; 278:11502-12; PMID:12514172; http://dx.doi.org/10.1074/jbc.M206579200
   PubMed Web of Science ®Google Scholar
• Cuetara BL, Crotti TN, O'Donoghue AJ, McHugh KP. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim 2006; 42:182-8; PMID:16948499; http://dx.doi.org/10.1290/0510075.1
   PubMed Web of Science ®Google Scholar
• Nakayama T, Mizoguchi T, Uehara S, Yamashita T, Kawahara I, Kobayashi Y, Moriyama Y, Kurihara S, Sahara N, Ozawa H, et al. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices–a simple method for identifying polarized osteoclasts. Bone 2011; 49:1331-9; PMID:21983021; http://dx.doi.org/10.1016/j.bone.2011.09.045
   PubMed Web of Science ®Google Scholar
• Xiong Q, Zhang LC, Zhang LH, Yao Q, Tang P. Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors. Chin J Orthop Traumatol 2013; 26:324-7
   Google Scholar
• Wang X, Luo Y, Liao WB, Zhang J, Chen TM. Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. Chin J Traumatol 2013; 16:277-80; PMID:24103822
   PubMedGoogle Scholar
• Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP. Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999; 274:13613-8; PMID:10224132; http://dx.doi.org/10.1074/jbc.274.19.13613
   PubMed Web of Science ®Google Scholar
• Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 2001; 16:348-60; PMID:11204435; http://dx.doi.org/10.1359/jbmr.2001.16.2.348
   PubMed Web of Science ®Google Scholar
• Luan X, Lu Q, Jiang Y, Zhang S, Wang Q, Yuan H, Zhao W, Wang J, Wang X. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. J Immunol 2012; 189:245-52; PMID:22664871; http://dx.doi.org/10.4049/jimmunol.1103387
   PubMed Web of Science ®Google Scholar
• Hakeda Y, Kobayashi Y, Yamaguchi K, Yasuda H, Tsuda E, Higashio K, Miyata T, Kumegawa M. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem Biophys Res Commun 1998; 251:796-801; PMID:9790989; http://dx.doi.org/10.1006/bbrc.1998.9523
   PubMed Web of Science ®Google Scholar
• Frederic Saltel AC, Edith Bonnelye, Pierre Jurdic. Actin cytoskeletal organisation in osteoclasts: A model to decipher transmigration and matrix degradation. Eur J Cell Biol 2008; 87:459-68; PMID:18294724; http://dx.doi.org/10.1016/j.ejcb.2008.01.001
   PubMed Web of Science ®Google Scholar
• Destaing O, Saltel F, Geminard JC, Jurdic P, Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell 2003; 14:407-16; PMID:12589043; http://dx.doi.org/10.1091/mbc.E02-07-0389
   PubMed Web of Science ®Google Scholar
• Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, De Camilli P, Baron R. The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol Biol Cell 2008; 19:394-404; PMID:17978100; http://dx.doi.org/10.1091/mbc.E07-03-0227
   PubMed Web of Science ®Google Scholar
• Chabadel A, Banon-Rodriguez I, Cluet D, Rudkin BB, Wehrle-Haller B, Genot E, Jurdic P, Anton IM, Saltel F. CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Mol Biol Cell 2007; 18:4899-910; PMID:17898081; http://dx.doi.org/10.1091/mbc.E07-04-0378
   PubMed Web of Science ®Google Scholar
• Luxenburg C, Geblinger D, Klein E, Anderson K, Hanein D, Geiger B, Addadi L. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS One 2007; 2:e179; PMID:17264882; http://dx.doi.org/10.1371/journal.pone.0000179
   PubMed Web of Science ®Google Scholar
• Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC, et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, α(v)β(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 2001; 152:181-95; PMID:11149930; http://dx.doi.org/10.1083/jcb.152.1.181
   PubMed Web of Science ®Google Scholar
• Harrison SC. Variation on an Src-like theme. Cell 2003; 112:737-40; PMID:12654240; http://dx.doi.org/10.1016/S0092-8674(03)00196-X
   PubMed Web of Science ®Google Scholar
• Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of α(v)beta3 integrin, and phosphorylated by src kinase. J Clin Invest 1998; 102:881-92; PMID:9727056; http://dx.doi.org/10.1172/JCI3212
   PubMed Web of Science ®Google Scholar
• Shyu JF, Shih C, Tseng CY, Lin CH, Sun DT, Liu HT, Tsung HC, Chen TH, Lu RB. Ru-Band Lu Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities. Bone 2007; 40:1329-42; PMID:17321230; http://dx.doi.org/10.1016/j.bone.2007.01.014
   PubMed Web of Science ®Google Scholar